Intrathecal baclofen for spastic hypertonia in brain injury

Journal of Head Trauma Rehabilitation

Volumn 12, Issue 1, 1997, Pages 87-90

  Meythaler, Jay M ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

BRAIN INJURY; CLINICAL TRIAL; CONFUSION; DROWSINESS; HUMAN; INFUSION PUMP; INTRATHECAL DRUG ADMINISTRATION; MULTICENTER STUDY; MUSCLE HYPERTONIA; REVIEW;

EID: 0031042811     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001199-199702000-00012     Document Type: Review

References (18)

1. Mann NH. Functional management of spasticity after head injury. J Neuro Rehabil. 1991;5:51-54.
2. Katz RT. Management of spasticity. Am J Phys Med Rehabil. 1988;67:108-116.
3. Glenn MB. Update on pharmacology: antispasticity medications in the patient with TBI. J Head Trauma Rehabil. 1986;1:71-72.
4. Dall JT, Harmon RL, Quinn CM. Use of clonidine for treatment of spasticity resulting from various forms of brain injury: a case series. Arch Phys Med Rehabil. 1994;75:1029A.
5. Kroin JS, Penn RD, Beissinger RL, Arzbaecher RC. Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res. 1984;54:191-194.
6. Terrence DV, Fromm GH. Complications of baclofen withdrawal. Arch Neurol. 1981;38:588-589.
7. Knuttson E, Lindblom U, Martensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci. 1974;23:473-484.
8. Hattab JR. Review of European clinical trials with baclofen. In: Feldman RG, Young RR, Kiella WP, eds. Spasticity. Disordered Motor Control. Chicago, Ill: Year Book Medical Publishers; 1980.
9. Sandy KR, Gillman MH. Baclofen-induced memory impairment. Clin Neuropharmacol. 1985;8:294-295.
10. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity: a prospective study. Am J Phys Med Rehabil. 1992;71:321-327.
11. Meythaler JM, Steers WD, Tuel SM, Sesco DV, Haworth CS. Use of intrathecal baclofen in familial spastic paraparesis. Arch Phys Med Rehabil. 1992;73. 794-797.
12. Coffey RJ, Cahill D, Steers W, and The Intrathecal Baclofen Multicenter Study Group. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993; 78:226-232.
13. Steers WD, Meythaler JM, Haworth CS, Park TS. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol. 1992;148:1,849-1,855.
14. Kroin JS, Penn RD. Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Rutgers AWF, eds. Parenteral Drug Therapy in Spasticity and Parkinson's Disease. Canforth, Parthenon Publishing; 1991.
15. Lazorthes Y, Sallerin-Caute B, Verdie J, Bastide R, Carillo J. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg. 1990;72: 393-402.
16. Terrence DV, Fromm GH. Complications of baclofen withdrawal. Arch Neurol. 1981;38:588-589.
17. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA. 1993;270:2,475-2,477.
18. Meythaler JM, DeVivo MJ, Hadley M. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil. 1996;77:461-466.